Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, February 1999, p. 240-245, Vol. 43, No. 2
Institute for Medical Microbiology,
University of Zürich, CH-8028 Zürich,
Switzerland,1 and
Department of
Microbiology, Hiroshima University School of Dentistry, Kasumi
1-2-3, Minami-ku, Hiroshima City, Hiroshima 734-8553, Japan2
Received 10 August 1998/Returned for modification 2 October
1998/Accepted 12 November 1998
The Staphylococcus aureus phosphoglucosamine mutase
gene glmM was shown to be the last gene of a
three-cistron operon, orf1-orf2-glmM. One
transcriptional start was identified upstream of orf1, and a second start producing a monocistronic transcript was identified upstream of glmM. Disruption of glmM abolished
GlmM production, decreased methicillin resistance, and resulted in
teicoplanin hypersusceptibility without affecting the production of the
endogenous penicillin-binding proteins and PBP 2'. Complementation of
the glmM mutation by the complete glmM
operon restored both methicillin resistance and normal teicoplanin
susceptibility. In contrast, a highly methicillin-resistant suppressor
mutant obtained by selection for growth in the presence of methicillin
remained GlmM deficient and teicoplanin hypersusceptible. The
suppressor mutation was not linked to the glmM operon but
was correlated with decreased autolysis and increased production of a
49-kDa protein, suggesting that there is an alternative
pathway for glucosamine-1-phosphate synthesis in S. aureus.
Methicillin resistance in
Staphylococcus aureus is due to an additional
penicillin-binding protein (PBP), PBP 2' (PBP 2a), which has a lower
affinity for methicillin than the four endogenous PBPs (26).
PBP 2' has in vitro transpeptidase activity (13), and its
activity is thought to substitute for the functions of the PBPs when
they are inactivated by high concentrations of Strains, plasmids, and culture conditions.
The strains and
plasmids used in this study are listed in Table
1. The strains were grown at 37°C in
Luria-Bertani (LB) medium (Difco, Detroit, Mich.). S. aureus
was transduced with bacteriophage 80
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
glmM Operon and Methicillin-Resistant
glmM Suppressor Mutants in Staphylococcus
aureus

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
-lactams. PBP 2' does
not contribute to the peptidoglycan composition in the absence of
methicillin, whereas in the presence of methicillin it seems to be able
to form only muropeptide dimers (8, 9). Methicillin
resistance levels are strain specific and may vary from very low to
high values. Characteristic for methicillin-resistant (Mcr)
S. aureus is the heterogeneous expression of the resistance with the production of a subpopulation of cells highly resistant to methicillin. This high level of resistance depends on chromosomally encoded genes (28) and can be achieved by different
mechanisms, one of which has been identified as the inactivation
of an autolytic activity (LytM) (12). A large number of
chromosomal genes, initially called fem or aux
factors (4, 10), are known to influence methicillin
resistance levels. These genes are involved, directly or indirectly, in
peptidoglycan metabolism. Any mutations that alter peptidoglycan
precursor composition and/or precursor formation, for instance,
inhibition of the lysine addition step in the stem peptide by the
femF mutation (25), reduction of
amidation of the stem peptide glutamate by femC
inactivation (14), or shortening of the pentaglycine
side chain by inactivation of the femAB operon (16,
30), reduce the level of methicillin resistance. The phosphoglucosamine mutase GlmM, initially identified as a
femD mutation (4), catalyzes the conversion of
glucosamine-6-phosphate to glucosamine-1-phosphate, which is an
early cytoplasmic step in peptidoglycan biosynthesis (19,
32). We show here that glmM is part of a
three-cistron operon and that inactivation of glmM can
be overcome by a suppressor mutation that leads to high-level methicillin resistance.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
, and transductants were
selected on LB plates containing either 20 µg of erythromycin
ml
1 or 10 µg of tetracycline ml
1.
Escherichia coli DH10B (Gibco BRL Life Technologies,
Gaithersburg, Md.) was transformed by electroporation, and
transformants were selected on LB plates containing either 50 µg of
ampicillin ml
1 or 10 µg of tetracycline
ml
1. Antibiotic susceptibility was determined by the
E test (AB BIODISK, Solna, Sweden) on Mueller-Hinton agar (Difco)
after 24 h of incubation at 35°C. The antibiotic resistance
profile of a culture (population analysis) was obtained
by plating aliquots of an overnight culture on freshly poured LB agar
plates containing increasing amounts of methicillin. The numbers of CFU
were counted after 48 h of incubation at 35°C. Spontaneous
autolysis of exponentially growing cells was determined in 0.05 M
Tris-HCl (pH 7.5) as the loss of turbidity at an optical density of
600 nm at 37°C (15).
TABLE 1.
Bacterial strains and plasmids used in this study
Cloning of glmM.
A 10.5-kb chromosomal XbaI
fragment from strain PG108 containing the right junction of
Tn551 was identified with a Tn551 probe, subcloned in plasmid pTZ18R (Genescribe-Z; United States Biochemical Corporation, Cleveland, Ohio), and subsequently used to probe a genomic
PstI library of strain BB270 in shuttle vector pAW8 (17), yielding recombinant plasmid pPG76 which contained a
5-kb PstI fragment covering the glmM operon (Fig.
1). For complementation of S. aureus, plasmids were first electroporated into the
restriction-negative, modification-positive strain S. aureus
RN4220 and were then transferred by phage 80
-mediated transduction
into the desired strain.
|
Molecular techniques. Standard techniques for DNA isolation, gel electrophoresis, blotting, and Southern and Northern hybridization procedures were used (23). Restriction enzymes, a randomly primed labelling kit, T4 DNA ligase, and calf intestinal alkaline phosphatase were purchased from Boehringer Mannheim (Mannheim, Germany), and T4 polynucleotide kinase was purchased from MBI Fermentas (Vilnius, Lithuania) and was used as recommended by the supplier. PCR was carried out with primers synthesized by Microsynth (Balgach, Switzerland) and AmpliTaq Gold polymerase from Perkin-Elmer (Rotkreuz, Switzerland). Primers were designed with OLIGO 4.01 primer analysis software (25a). The primers used for amplification and reverse transcription (RT)-PCR (RT-PCR) were 1 (5' [nucleotide {nt} 107]-TGATTTAGGACCAACAGC), 2 (5' [nt 968]-ACCTAATGAAACCGCCTG), 3 (5' [nt 1307]-AGGGAACTAAAGCGATAC), 4 (5' [nt 2025]-GGGGCTTGAGATTTATTG), 5 (5' [nt 3286]-CAACTGGATTATGAGAGG), 6 (5' [nt 3426]-TTACTTTGAAGGGGC), and 7 (5' [nt 4116]-TTTATCTGTTACGCG).
DNA sequence analysis. Restriction fragments of the 5-kb insert of pPG76 were subcloned in pTZ18R. The DNA was sequenced with the ALF sequenator (Pharmacia, Uppsala, Sweden) with the Thermo Sequenase fluorescence-labelled primer cycle sequencing kit with 7-deaza-dGTP from Amersham (Buckinghamshire, United Kingdom). DNA sequences were analyzed with the DNA Inspector IIe program (Textco, Inc., West Lebanon, N.H.) and the Genetics Computer Group program (University of Wisconsin Genetics Computer Group, Madison) (31a). Amino acid sequence similarities were searched for by comparison of the sequence with those in the SwissProt and TREMBL data banks.
Northern blot analysis.
RNA was isolated from exponentially
growing cells as described by Kullik and Giachino (22). The
probes used for the Northern hybridization were obtained by PCR
amplification with primers 1 and 2 or primers 6 and 7 (Fig. 1), and the
probes were labelled with [
-32P]dCTP with the random
primed labelling kit of Boehringer Mannheim.
RT-PCR. RT of the mRNA was performed with reverse transcriptase H from Gibco with primer 5 or 7. The cDNA was amplified by PCR in a Perkin-Elmer Cetus DNA thermal cycler with the following primer pairs: 4 and 7, 4 and 5, and 3 and 5. Controls for detection of contaminating double-stranded DNA were made by amplifying the RNA preparations without prior RT.
Primer extension. Primer extension analysis was carried out as described by Storz and Altuvia (29). Primers 8 [5' [nt 1315]-TAGTTCCCTTAAAGACCGTGATGAG) and 9 (5' [nt 3088]-TTTCACCTTTATTATGTGCTAGAAC) were used.
Membrane proteins and PBPs.
Membranes of cells grown
overnight at 30°C were prepared by differential centrifugation, the
PBPs were labelled with 10 µg of
[phenyl-4(n)-3H]benzylpenicillin
ml
1 (final concentration; 11.9 Ci mmol
1;
Amersham Life Sciences) for 10 min at 30°C and were separated on
sodium dodecyl sulfate-polyacrylamide gels, as described earlier (5). The proteins were stained with Coomassie brilliant
blue, and the PBPs were visualized by fluorography after 4 weeks of exposure to X-ray film at
70°C.
Western blots.
Recombinant GlmM protein was obtained by
cloning glmM into a pFLAG MAC vector (IBI Escherichia
coli FLAG expression system; International Biotechnologies Inc.,
Eastman Kodak Company) (20). The recombinant GlmM containing
the hydrophilic FLAG peptide Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys was
purified according to the manufacturer's recommendations and was used
to prepare rabbit anti-GlmM antiserum. Western blotting was performed
with cytoplasmic extracts of overnight cultures that were lysed in
phosphate-buffered saline containing 1 mM phenylmethylsulfonyl fluoride
and 100 µg of lysostaphin ml
1 and that were resolved on
a sodium dodecyl sulfate-10% polyacrylamide gel. Rabbit anti-GlmM
serum was used as a first antibody. Immunodetection was performed as
described in the manual supplied with Chemoluminescence Reagent Plus
(NEN Life Science Products, Boston, Mass.). Human immunoglobulin G was
added at a concentration of 42 µg ml
1 to all reaction
mixtures to saturate the Fc binding sites of protein A. Controls were
made with the preimmune serum and with anti-FLAG monoclonal antibodies.
Nucleotide sequence accession number. The nucleotide sequence of the 5-kb fragment can be accessed in the EMBL/GenBank under accession no. Y15477.
| |
RESULTS |
|---|
|
|
|---|
Phenotype of glmM disruption and Mcr
suppressor mutants.
Disruption of glmM (synomymous with
femD) by Tn551 reduced the level of resistance to
methicillin as well as the number of subclones of strain PG108 growing
in the presence of >10 µg of methicillin ml
1 compared
to the growth of the Mcr parent BB270 (Fig.
2). All highly resistant subclones were
still erythromycin resistant (Emr) and were thus still
carrying the Tn551 insert. A representative of these
subclones, strain PG100, was analyzed in more detail. It showed
greatly increased resistance to different
-lactams (Table
2) and produced a larger proportion of
highly Mcr subclones compared to the proportion produced by
BB270 (Fig. 2). Spontaneous autolysis was found to be lower in PG100
than in BB270 and PG108 (Fig. 3). These
properties were also stable after repeated subcultivation under
nonselective conditions and storage at
70°C. Backcrosses of
Emr from PG100 into BB270 yielded methicillin-susceptible
(Mcs) transductants with the same phenotype as PG108,
represented here by strain PG105 (Fig. 2). This, plus the identical
hybridization patterns of different chromosomal digests of PG105,
PG100, and PG108 obtained when they were probed with Tn551
DNA (data not shown), confirmed that glmM was still
disrupted in Mcr subclone PG100. The high level of
methicillin resistance of strain PG100 was not cotransducible with
Emr. A suppressor or compensatory mutation, termed here
hmrD1 (standing for high-level methicillin-resistant
suppressor mutant of femD), that led to the highly resistant
phenotype was therefore postulated to have occurred in PG100 at a
location not linked to glmM. Disruption of glmM
increased the level of
-lactam susceptibility as well as the level
of teicoplanin susceptibility in both Mcr BB270 and
Mcs BB255, as shown by strains PG108 and PG27,
respectively (Table 2); it had no effect, however, on vancomycin
susceptibility. Interestingly, in the Mcr suppressor
mutant PG100, the level of teicoplanin susceptibility remained lower.
The hmrD1 mutation therefore suppressed only methicillin sensitivity, whereas teicoplanin hypersusceptibility seemed to be
linked to the still inactivated glmM operon.
|
|
|
Western blot, PBP, and membrane protein patterns in glmM mutants. A Western blot with anti-GlmM antibodies showed, as anticipated, that the phosphoglucomutase was absent from both mutant PG108 and Mcr suppressor mutant PG100, whereas it was overproduced in complemented strain PG79 (Fig. 4). The smaller bands seen in Fig. 4 are thought to be degradation products due to GlmM overproduction. The GlmM protein migrated at a slightly higher position than expected from its calculated size. A small 32-kDa band of unknown origin and nature reacted with GlmM antibodies for all strains, irrespective of the presence of the glmM mutation. Inactivation of glmM had no influence on the production of PBP 2' or on that of the other PBPs. The corresponding PBP bands had similar intensities in wild-type strain BB270 and mutant strain PG108 as well as in suppressor mutant strain PG100 (Fig. 5B). When strain BB270 was grown in the presence of methicillin, all PBPs except the low-affinity PBP 2' and a fraction of PBP 2 were saturated with methicillin and could not be labelled with [3H]penicillin (Fig. 5B, lane c). In the membrane protein pattern of strain PG100 an intense 49-kDa band appeared. This band was either less prominent in or absent from the other strains (Fig. 5A), suggesting that it may result from the postulated suppressor mutation hmrD1.
|
|
Cloning of glmM and complementation of a
glmM mutant.
The wild-type glmM gene was
cloned on a 5-kb PstI fragment from strain BB270 into
shuttle vector pAW8, yielding plasmid pPG76. This plasmid restored
resistance to methicillin in PG108, as seen in strain PG79, which
showed the same resistance profile as BB270 (Fig. 2). In contrast to
suppressor mutant PG100, PG79 showed normal teicoplanin susceptibility
(Table 2). The shuttle vector pAW8 alone had no effect on
-lactam
resistance or teicoplanin hypersusceptibility, as shown by the results
for strain PG217 (Table 2).
DNA sequence.
The 5-kb PstI fragment of pPG76
contained four open reading frames (ORFs), all oriented in the same
direction (Fig. 1). The first ORF codes for a 302-amino acid (aa)
protein with a calculated molecular mass of 33 kDa. Its sequence showed
53% identity and 73% similarity in a 300-aa overlap to the sequence
of the arginase of Bacillus caldovelox (Swissprot accession
no. p53608) and 52% identity and 72% similarity to that of B. subtilis (Swissprot accession no. p39138). The identity around the
active site was over 70%. This ORF was therefore named
argI. It was followed by a stretch of T residues with a
preceding dyad symmetry characteristic for factor-independent RNA
polymerase terminators (6). The second ORF, termed
orf1, codes for a 269-aa protein of 29.6 kDa. Its sequence
has 56% identity and 76% similarity to the sequence of a hypothetical
protein encoded by ybbP in Bacillus subtilis. Two
hydrophobic regions at the C-terminal region suggest that it may be
membrane associated. The third ORF, orf2, separated by 4 nucleotides from orf1, encoded a 310-aa protein of 34 kDa. Its sequence had 28% identity and 53% similarity to the sequence of a
hypothetical protein encoded by ybbR in B. subtilis. The fourth ORF, separated by 29 nt from orf2,
is glmM coding for 451-aa protein of 49 kDa. The
glmM DNA sequence is identical to that of the
phosphoglucosamine mutase gene glmM in strain COL (19, 32) except for a single T-to-C difference at position 3719 which results in the change of a valine to an alanine at position 251. Tn551 truncates the terminal 99 residues of GlmM in strain
PG108. The truncated GlmM still harbors the active site that
contains the phosphogluco- and phosphomannomutase phosphoserine
signature located between aa 91 and 95, 95 and 110, and 111 and 115. A
factor-independent RNA polymerase terminator was identified
downstream of glmM. The transcriptional start of
orf1 and a second start preceding glmM were
identified from RNA isolated from exponentially growing S. aureus containing plasmid pPG76 (Fig.
6). Two transcriptional starts separated
by 3 nt were apparent for orf1. The positions of the
transcriptional starts were confirmed with further primers (data not
shown). Putative
35 and
10 sequences and ribosome-binding sites
preceding argI, orf1, and glmM were
identified. No obvious ribosome-binding site or putative
35 and
10 sequences were identifiable upstream of orf2.
|
Transcription of the glmM region. RNA extracted from exponentially growing mutant PG108, parents BB255 and BB270, and suppressor mutant PG100 were analyzed by Northern blotting with a 0.69-kb glmM-internal probe (Fig. 1) covering the Tn551 insertion site. Strains BB255 and BB270 showed three transcripts of 3.2, 2.2, and 1.3 kb with increasing intensities (Fig. 7A). As deduced from their sizes, the 3.2-kb band was thought to be a transcript covering the three ORFs, orf1-orf2-glmM, and the 2.2-kb transcript was thought to be a degradation product of that transcript. The 1.3-kb transcript was thought to originate from glmM, since it was absent from strains PG108 and PG100, which carried the Tn551-inactivated glmM, and was substituted for by a larger and weaker band of about 4.7 kb, presumably a readthrough product into Tn551.
|
| |
DISCUSSION |
|---|
|
|
|---|
The phosphoglucosamine mutase GlmM catalyzes the conversion
of glucosamine-6-phosphate to glucosamine-1-phosphate (19,
32), the initial step in the formation of the nucleotide
sugar UDP-N-acetylglucosamine, which is involved in
peptidoglycan biosynthesis. The final structure and
composition of the peptidoglycan are only marginally affected in glmM mutants. The main changes are a 5% lower
peptidoglycan cross-linking compared to that in the wild type
and a reduction of a minor component of the peptidoglycan that contains
an alanyl-tetraglycine instead of a pentaglycine substituent on the
lysine
-amino group (27). That such minor changes result
in methicillin susceptibility may be explained by a lower rate of
production of peptidoglycan precursors that is insufficient to support
the protective action of PBP 2' in competition with methicillin. In
E. coli the glmM gene is essential
(24). Since in S. aureus GlmM inactivation is
tolerated and only marginally affects the peptidoglycan, there may be
an alternative pathway for glucosamine-1-phosphate synthesis in
S. aureus.
Since GlmM is involved in an early step of UDP-N-acetylglucosamine synthesis, not only peptidoglycan precursor formation but also wall teichoic acid substitution of the peptidoglycan may have been affected (11). However, the amount of wall teichoic acid, its composition, and N-acetylglucosaminyl substitution were indistinguishable in stationary-phase cultures of BB270 and PG108 (18), as were the plating efficiencies of phages, which depend on the N-acetylglucosaminyl modification of the wall teichoic acid (7).
The phosphoglucosamine mutase was found to be the last gene of the three-cistron operon structure orf1-orf2-glmM. A second monocistronic transcript was shown to originate from glmM. Upon Tn551-mediated glmM inactivation, the monocistronic glmM transcript disappeared and was replaced by a weaker and longer transcript. Unlike Tn551 inserts in femAB (2) or femC (14), in which Tn551-interrupted transcripts increase by 5.2 kb due to Tn551, the Tn551-interrupted glmM transcript increased by less than 5.2 kb, perhaps due to different processing of the mRNA. Although this transcript may code for a truncated GlmM product, GlmM protein production was completely abolished, as shown by Western blotting, in the mutant as well as in the suppressor mutant PG100. The nature of the 32-kDa protein that reacted with the anti-GlmM antibodies that was present in all strains analyzed needs to be studied further.
A gene organization similar to that of the glmM operon is found in the B. subtilis genome (ybbP-ybbR-ybbT), where the sequences of YbbP, YbbR, and YbbT have identities of 56, 28, and 67% to those of ORF1, ORF2, and GlmM, respectively. The upstream argI transcript was clearly independent from the glmM operon, although argI transcription was increased in glmM-inactivated strains, which may point to a complex interaction between the glmM operon and arginase transcription.
Interestingly, the suppressor mutation hmrD1 in PG100 restored only methicillin resistance but did not alter teicoplanin hypersusceptibility. The glycopeptide teicoplanin inhibits both transglycosylation and transpeptidation by binding to the terminal D-Ala-D-Ala of the peptidoglycan precursor, enhancing its activity by its membrane anchor (1). This suggests that, besides GlmM activity, a membrane component may be affected in the glmM mutants since the hydropathy profile predicts that ORF1 is a membrane-associated protein. This may be the reason for the teicoplanin hypersusceptibility.
The decreased spontaneous autolysis, plus the higher level of production of a 49-kDa membrane protein, may be due to the suppressor mutation in PG100. A compensatory mutation leading to high-level Mcr also occurs in femC mutants (31). The nature of these compensatory mutations is unknown. There is evidence that several different mechanisms may be able to confer high-level methicillin resistance (31). One of these mechanisms was shown to be by inactivation of an autolytic activity (12). A similar mechanism may act here since PG100 showed decreased autolysis as well.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by Swiss National Science Foundation grant 31-42182.94 and Jubiläumsspende der Universität Zürich.
We thank K. Shaw for fruitful discussions.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Institute for Medical Microbiology, University of Zürich, Gloriastr. 32, P.O. Box, CH8028 Zürich, Switzerland. Phone: 41-1 634 26 50. Fax: 41-1 634 49 06. E-mail: bberger{at}immv.unizh.ch.
Present address: Curtin University of Technology, P.O.
Box U1987, Perth 6001, Western Australia.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Beauregard, D. A., D. H. Williams, M. N. Gwynn, and D. J. C. Knowles. 1995. Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics. Antimicrob. Agents Chemother. 39:781-785[Abstract]. |
| 2. | Berger-Bächi, B., L. Barberis-Maino, A. Strässle, and F. H. Kayser. 1989. FemA, a host-mediated factor essential for methicillin resistance in Staphylococcus aureus: molecular cloning and characterization. Mol. Gen. Genet. 219:263-269[Medline]. |
| 3. | Berger-Bächi, B., and M. L. Kohler. 1983. A novel site on the chromosome of Staphylococcus aureus influencing the level of methicillin resistance: genetic mapping. FEMS Microbiol. Lett. 20:305-309. |
| 4. |
Berger-Bächi, B.,
A. Strässle,
J. E. Gustafson, and F. H. Kayser.
1992.
Mapping and characterization of multiple chromosomal factors involved in methicillin resistance in Staphylococcus aureus.
Antimicrob. Agents Chemother.
36:1367-1373 |
| 5. | Berger-Bächi, B., A. Strässle, and F. H. Kayser. 1986. Characterization of an isogenic set of methicillin-resistant and -susceptible mutants of Staphylococcus aureus. Eur. J. Clin. Microbiol. 5:697-701[Medline]. |
| 6. |
Brendel, V., and E. N. Trifonov.
1984.
A computer algorithm for testing potential prokaryotic terminators.
Nucleic Acids Res.
12:4411-4427 |
| 7. | Coyette, J., and J. M. Ghuysen. 1968. Structure of the cell wall of Staphylococcus aureus, strain Copenhagen. IX. Teichoic acid and phage adsorption. Biochemistry 7:2385-2389[Medline]. |
| 8. |
de Jonge, B. L. M.,
Y. S. Chang,
D. Gage, and A. Tomasz.
1992.
Peptidoglycan composition in heterogeneous Tn551 mutants of a methicillin-resistant Staphylococcus aureus strain.
J. Biol. Chem.
267:11255-11259 |
| 9. |
de Jonge, B. L. M., and A. Tomasz.
1993.
Abnormal peptidoglycan produced in a methicillin-resistant strain of Staphylococcus aureus grown in the presence of methicillin: functional role for penicillin-binding protein 2A in cell wall synthesis.
Antimicrob. Agents Chemother.
37:342-346 |
| 10. |
de Lencastre, H., and A. Tomasz.
1994.
Reassessment of the number of auxiliary genes essential for expression of high-level methicillin resistance in Staphylococcus aureus.
Antimicrob. Agents Chemother.
38:2590-2598 |
| 11. | Fischer, W. 1990. Bacterial phosphoglycolipids and lipoteichoic acids, p. 123-234. In M. Kates (ed.), Glycolipids, phosphoglycolipids, and sulfoglycolipids. Plenum Press, New York, N.Y. |
| 12. |
Fujimura, T., and K. Murakami.
1997.
Increase of methicillin resistance in Staphylococcus aureus caused by deletion of a gene whose product is homologous to lytic enzymes.
J. Bacteriol.
179:6294-6301 |
| 13. | Gaisford, W. C., and P. E. Reynolds. 1989. Methicillin resistance in Staphylococcus epidermidis. Relationship between the additional penicillin-binding protein and an attachment transpeptidase. Eur. J. Biochem. 185:211-218[Medline]. |
| 14. |
Gustafson, J.,
A. Strässle,
H. Hächler,
F. H. Kayser, and B. Berger-Bächi.
1994.
The femC locus of Staphylococcus aureus required for methicillin resistance includes the glutamine synthetase operon.
J. Bacteriol.
176:1460-1467 |
| 15. |
Gustafson, J. E.,
B. Berger-Bächi,
A. Strässle, and B. J. Wilkinson.
1992.
Autolysis of methicillin-resistant and -susceptible Staphylococcus aureus.
Antimicrob. Agents Chemother.
36:566-572 |
| 16. |
Henze, U.,
T. Sidow,
J. Wecke,
H. Labischinski, and B. Berger-Bächi.
1993.
Influence of femB on methicillin resistance and peptidoglycan metabolism in Staphylococcus aureus.
J. Bacteriol.
175:1612-1620 |
| 17. | Ishiwa, H., and N. Tsuchida. 1984. New shuttle vectors for Escherichia coli and Bacillus subtilis. I. Construction and characterization of plasmid pHY460 with twelve unique cloning sites. Gene 32:129-134[Medline]. |
| 18. | Jenni, R., and B. Berger-Bächi. 1998. Teichoic acid content in different lineages of Staphylococcus aureus NCTC8325. Arch. Microbiol. 170:171-178[Medline]. |
| 19. |
Jolly, L.,
S. W. Wu,
J. Van Heijenoort,
H. De Lencastre,
D. Mengin Lecreuix, and A. Tomasz.
1997.
The femR315 gene from Staphylococcus aureus, the interruption of which results in reduced methicillin resistance, encodes a phosphoglucosamine mutase.
J. Bacteriol.
179:5321-5325 |
| 20. | Komatsuzawa, H., K. Ohta, M. Sugai, T. Fujiwara, J. Suzuki, B. Berger-Bächi, and H. Suginaka. Tn551-insertional inactivation of fmtB gene renders methicillin-resistant Staphylococcus aureus susceptible to oxacillin and Triton X-100. Submitted for publication. |
| 21. | Kreiswirth, B. N., S. Löfdahl, M. J. Bentley, M. O'Reilly, P. M. Schlievert, M. S. Bergdoll, and R. P. Novick. 1983. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature 305:680-685. |
| 22. |
Kullik, I., and P. Giachino.
1997.
The alternative sigma factor sigma(b) in Staphylococcus aureus regulation of the sigB operon in response to growth phase and heat shock.
Arch. Microbiol.
167:151-159[Medline].
|
| 23. | Maniatis, T., E. F. Fritsch, and J. E. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 24. |
Mengin-Lecreulx, D., and J. van Heijenoort.
1996.
Characterization of the essential gene glmM encoding phosphoglucosamine mutase in Escherichia coli.
J. Biol. Chem.
271:32-39 |
| 25. |
Ornelas-Soares, A.,
H. de Lencastre,
B. L. M. de Jonge, and A. Tomasz.
1994.
Reduced methicillin resistance in a new Staphylococcus aureus transposon mutant that incorporates muramyl dipeptides into the cell wall peptidoglycan.
J. Biol. Chem.
269:27246-27250 |
| 25a. | Rejchlik, W. 1992. OLIGO X.01 primer analysis software. National Biosciences Inc, Plymouth, Minn. |
| 26. | Reynolds, P. E., and D. F. Brown. 1985. Penicillin-binding proteins of beta-lactam-resistant strains of Staphylococcus aureus. Effect of growth conditions. FEBS Lett. 192:28-32[Medline]. |
| 27. | Roos, M. H. H. 1995. Das Murein von Staphylococcus aureus. Untersuchung des Einflusses von Antibiotikaresistenzdeterminanten auf die Feinstruktur des Peptidoglykan von Staphylococcus aureus. Ph.D. thesis. Freie Universität Berlin, Berlin, Germany. |
| 28. |
Ryffel, C.,
A. Strässle,
F. H. Kayser, and B. Berger-Bächi.
1994.
Mechanisms of heteroresistance in methicillin-resistant Staphylococcus aureus.
Antimicrob. Agents Chemother.
38:724-728 |
| 29. | Storz, G., and S. Altuvia. 1994. OxyR regulon. Methods Enzymol. 234:217-223[Medline]. |
| 30. |
Strandén, A. M.,
K. Ehlert,
H. Labischinski, and B. Berger-Bächi.
1997.
Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus.
J. Bacteriol.
179:9-16 |
| 31. | Strandén, A. M., M. Roos, and B. Berger-Bächi. 1996. Glutamine synthetase and heteroresistance in methicillin-resistant Staphylococcus aureus. Microb. Drug Resist. 2:201-207. [Medline] |
| 31a. | University of Wisconsin Genetics Computer Group. 1994. Program manual for the Wisconsin package, version 8. University of Wisconsin Genetics Computer Group, Madison. |
| 32. | Wu, S. W., H. De Lencastre, A. Sali, and A. Tomasz. 1996. A phosphoglucomutase-like gene essential for the optimal expression of methicillin resistance in Staphylococcus aureus: molecular cloning and DNA sequencing. Microb. Drug Resist. 2:277-286. [Medline] |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»